| |
| |
|
| Insider
Information: |
Mahon Paul A |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
36,710 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,017,425 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,710 |
|
|
| Total
Value |
$10,017,425 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
United Therapeutics Corp |
UTHR |
|
2024-04-04 |
36,710 |
2004-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• – – |
2012-02-02 |
4 |
AS |
$50.00 |
$3,600,000 |
D/D |
(72,000) |
33,600 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• • – |
2015-08-20 |
4 |
D |
$162.66 |
$3,253,200 |
D/D |
(20,000) |
35,054 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• • – |
2012-07-05 |
4 |
AS |
$52.30 |
$3,138,000 |
D/D |
(60,000) |
33,600 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• – – |
2011-03-03 |
4 |
AS |
$68.94 |
$3,048,198 |
D/D |
(44,000) |
33,600 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• – – |
2010-10-07 |
4 |
AS |
$55.29 |
$2,847,019 |
D/D |
(51,488) |
25,500 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2022-12-15 |
4 |
AS |
$120.26 |
$2,355,722 |
D/D |
(12,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• – – |
2012-02-02 |
4 |
OE |
$25.32 |
$1,822,680 |
D/D |
72,000 |
105,600 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2022-12-01 |
4 |
AS |
$275.25 |
$1,665,876 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-01-05 |
4 |
AS |
$273.08 |
$1,642,915 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2022-11-17 |
4 |
AS |
$257.93 |
$1,554,296 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-01-19 |
4 |
AS |
$258.42 |
$1,553,683 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2022-11-03 |
4 |
AS |
$254.12 |
$1,542,494 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-02-02 |
4 |
AS |
$254.17 |
$1,527,794 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• • – |
2012-07-05 |
4 |
OE |
$25.32 |
$1,518,900 |
D/D |
60,000 |
93,600 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-02-16 |
4 |
AS |
$248.67 |
$1,494,922 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• – – |
2010-10-07 |
4 |
OE |
$27.97 |
$1,460,448 |
D/D |
51,488 |
76,988 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-03-02 |
4 |
AS |
$241.17 |
$1,455,418 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2022-07-07 |
4 |
AS |
$240.46 |
$1,452,237 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-12-07 |
4 |
AS |
$238.88 |
$1,433,331 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• • – |
2014-12-04 |
4 |
AS |
$129.05 |
$1,429,123 |
D/D |
(11,000) |
34,832 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-03-07 |
4 |
AS |
$236.90 |
$1,424,309 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• • – |
2014-11-20 |
4 |
AS |
$128.72 |
$1,419,239 |
D/D |
(11,000) |
34,832 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-03-21 |
4 |
AS |
$234.11 |
$1,418,726 |
D/D |
(6,000) |
36,710 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-08-03 |
4 |
AS |
$232.96 |
$1,417,470 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & General Counsel |
• • – |
2014-12-18 |
4 |
AS |
$128.19 |
$1,397,828 |
D/D |
(10,750) |
34,832 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
